DE69219219D1 - Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl - Google Patents

Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl

Info

Publication number
DE69219219D1
DE69219219D1 DE69219219T DE69219219T DE69219219D1 DE 69219219 D1 DE69219219 D1 DE 69219219D1 DE 69219219 T DE69219219 T DE 69219219T DE 69219219 T DE69219219 T DE 69219219T DE 69219219 D1 DE69219219 D1 DE 69219219D1
Authority
DE
Germany
Prior art keywords
pyridazinones
platelet counts
reduce platelet
atom
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69219219T
Other languages
English (en)
Other versions
DE69219219T2 (de
Inventor
Mitsuyoshi Nakashima
Nobuyuki Kikuchi
Misao Miyamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Publication of DE69219219D1 publication Critical patent/DE69219219D1/de
Application granted granted Critical
Publication of DE69219219T2 publication Critical patent/DE69219219T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69219219T 1991-07-05 1992-06-24 Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl Expired - Fee Related DE69219219T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3165670A JPH0517357A (ja) 1991-07-05 1991-07-05 血小板減少療法剤

Publications (2)

Publication Number Publication Date
DE69219219D1 true DE69219219D1 (de) 1997-05-28
DE69219219T2 DE69219219T2 (de) 1997-08-14

Family

ID=15816796

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69219219T Expired - Fee Related DE69219219T2 (de) 1991-07-05 1992-06-24 Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl

Country Status (6)

Country Link
US (1) US5219854A (de)
EP (1) EP0521381B1 (de)
JP (1) JPH0517357A (de)
AT (1) ATE151987T1 (de)
CA (1) CA2073117A1 (de)
DE (1) DE69219219T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0742211B1 (de) * 1994-01-25 2000-05-10 Nissan Chemical Industries, Limited Pyridazinon-derivate
EP0665223A1 (de) * 1994-01-28 1995-08-02 Takeda Chemical Industries, Ltd. Antitumormittel, 3(2H)-Pyridazinon-Derivate und ihre Herstellung
US6103740A (en) * 1997-08-21 2000-08-15 Eli Lilly And Company Methods for lowering platelet counts
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892947A (en) * 1985-04-27 1990-01-09 Nissan Chemical Industries Ltd. 3(2H)Pyridazinone, process for its preparation and anti-allergic agent containing it
HU198696B (en) * 1987-01-20 1989-11-28 Nissan Chemical Ind Ltd Process for producing 3/2h/-pyridazinon derivatives and pharmaceutical compositions containing them as active components

Also Published As

Publication number Publication date
US5219854A (en) 1993-06-15
EP0521381B1 (de) 1997-04-23
CA2073117A1 (en) 1993-01-06
JPH0517357A (ja) 1993-01-26
DE69219219T2 (de) 1997-08-14
ATE151987T1 (de) 1997-05-15
EP0521381A1 (de) 1993-01-07

Similar Documents

Publication Publication Date Title
EP1035123A4 (de) Neue heterozyklische verbindungen
ES2045109T3 (es) 1-fenil-3-naftaleniloxipropanaminas.
MX9202844A (es) 1-indolilalquil-4-( alcoxi-pirimidinil) piperazinas y composicion farmaceutica que las contiene.
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
DE3462894D1 (de) 3-indolecarboxamide compounds
DE69219219D1 (de) Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl
DK0476854T3 (da) Farmaceutisk komposition til at hæmme blodpladeaggregation
DE69001004T2 (de) Zusammensetzung gegen leberkrankheiten.
EP0201349A3 (de) Tetrazolderivate
KR890009886A (ko) 심기능 부전의 예방 및 치료제
DE3782229T2 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DE3884878D1 (de) Uricosuretische Zusammensetzung.
EP0919233B8 (de) Therapeutisches mittel zur behandlung von nierenerkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee